跳至主要内容
临床试验/NCT05821322
NCT05821322终止不适用

Evaluating the Appropriate Blood Glucose Target Before and During Moderate Intensity Aerobic Exercise in Adults With Type 1 Diabetes Using Do-it-yourself Automated Insulin Delivery (AID) Systems (the GUARDIA [GlUcose tARget DIY-AID] Trial)"

Institut de Recherches Cliniques de Montreal1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2023年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
发起方
入组人数
6
试验地点
1
主要终点
Change in plasma glucose during exercise

研究概览

简要总结

Despite major technological advances in type 1 diabetes (artificial pancreas), the management of hypoglycemia remains a major challenge, especially during and after physical activity. The primary outcome is to determine the temporary blood glucose (BG) target to be set 60 minutes before aerobic exercise in people with type 1 diabetes (PWT1D) using do-it-yourself automated insulin delivery (DIY-AID) systems. Three glycemic thresholds to be applied 60 minutes before physical activity will be tested in 32 people on AID-DIY: 8.3 (current target for commercial AID systems), 8.8, and 9.3 mmol/L. Each participant will perform 3 sessions of moderate aerobic physical activity (ergocycle) at 60% of vo2peak with a different glycemic target each time (random order). Plasma glucose will be measured every 20 minutes before and during physical activity, and blood glucose measured by continuous glucose reading (DEXCOM) for 24 hours post-intervention. Once the best glycemic target is selected, participants could come to the research center for 1 or 2 more voluntary interventions to test the threshold during 1) fasting exercise and 2) late luteal phase of the menstrual cycle.

详细描述

This study follows a randomized, cross-over design and aims to test tree temporary BG targets (8.3, 8.8 and 9.3 mmol/L), resulting in 3 intervention visits per participants. A total of 32 participants will be recruited and randomized for this study.

Intervention visit:

  • Participants will be admitted at the research center (IRCM; Montréal or Alberta) at 15:30.
  • A venous catheter will be installed for plasma glucose and insulin measurements.
  • At 16:00, the temporary BG target will be set in the DIY-AID system and blood sampling will begin.
  • At 16:40, if glucose is < 5.5 mmol/L, 16g carbohydrate (CHO; 4 Dex4®) will be provided.
  • At 16:55, a smaller sample will be taken only to verify glucose level. If glucose is < 5.5 mmol/L, 16g CHO (4 Dex4®) will be provided and exercise start will be postponed by at least 15 minutes or until glucose level is > 5.5 mmol/L. If more than three CHO intake are needed, the test will be canceled and rescheduled.
  • At 17:00, exercise will be started if glucose is > 5.5 mmol/L. The exercise will consist of 60 minutes on the ergocycle at 60% of pre-determined VO2peak (moderate intensity).
  • At 18:00, exercise and temporary BG target will be stopped. Blood sampling will continue for 1-hr during recovery.
  • At 19:00, participant will be discharged. If glucose level is below 5.0 mmol/L, a snack of 16g CHO (4 Dex4®) will be offered. Participants will have the option to bring their dinner and eat it at the research facility before leaving if they prefer.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females aged between 18 and 65 years old.
  • Clinical diagnosis of type 1 diabetes for 1 year. (Note: The diagnosis of type 1 diabetes is based on the investigator's judgment; C peptide level and antibody determinations are not needed.)
  • Treatment using DIY-AID system for 3 months.
  • Own a smartphone or tablet to use the mobile application: Keenoa, Fitbit App
  • Using Dexcom G6 and willing to share CGM data with the research team.
  • Using rapid- (e.g., Aspart, Lispro or Glulisine) or ultra-rapid (e.g., FiAsp) acting insulin analogs.
  • HbA1c < 8.5%.

排除标准

  • Major complication within the previous 3 months (e.g., severe hypoglycemia requiring assistance, diabetic ketoacidosis, or cardiovascular event).
  • Restriction in PA due to significant diabetes complications (e.g., severe peripheral neuropathy, active proliferative retinopathy, etc.) or other type of limitations (e.g., orthopedic, severe arthritis, etc.). Uncontrolled hypertension (e.g., blood pressure > 150 mmHg systolic or > 95 mmHg diastolic).
  • Ongoing pregnancy or breastfeeding.
  • Inability to give consent.

研究组 & 干预措施

Temporary target of 8.3 mmol/L

Active Comparator

Current commercial artificial pancreas thresholds. Temporary target set 60 minutes before the intervention.

干预措施: Physical activity trial intervention (Other)

Temporary target of 8.8 mmol/L

Experimental

Temporary target set 60 minutes before the intervention

干预措施: Physical activity trial intervention (Other)

Temporary target of 9.3 mmol/L

Experimental

Temporary target set 60 minutes before the intervention

干预措施: Physical activity trial intervention (Other)

结局指标

主要结局

Change in plasma glucose during exercise

时间窗: 60 minutes (during exercice)

To determine the temporary blood glucose (BG) target to be set 60 minutes before aerobic exercise in PWT1D using DIY-AID systems which will be associated with the smallest change in glucose during exercise by testing the targets of 8.3 (current target for commercial AID systems), 8.8, and 9.3 mmol/L.

次要结局

  • Time in range during exercice: menstrual cycle phases(60 minutes (during exercice))
  • Number of participants who required oral treatment during exercise(60 minutes (during exercice))
  • Time in range (during fasting exercice)(60 minutes (during exercice))
  • Number of hypoglycemic episodes(60 minutes (during exercice))
  • Lowest plasma glucose(60 minutes (during exercice))
  • Insulin on board (units)(60 minutes (during exercice))
  • Mean CGM glucose(24 hours post-exercice)
  • Plasma insulin(60 minutes (during exercice))
  • Plasma glucose at 60 minutes(60 minutes)
  • Carbohydrate consumption (g)(60 minutes (during exercice))
  • Percent time in range, in hypoglycemia and in hyperglycemia(midnight to 6 am)
  • Coefficient of variation(24 hours post-exercice)
  • Hypoglycemia with treatment(midnight to 6 am)
  • Glucose variability(24 hours post-exercice)
  • Number of participants requiring an oral treatment for hypoglycemia(24 hours post-exercice)
  • Carbohydrate needed (g)(24 hours post-exercice)
  • Percent time in range, in hypoglycemia and in hyperglycemia(6 hours post-exercice)
  • Glucose variability(midnight to 6 am)
  • Coefficient of variation(midnight to 6 am)
  • Number of participants requiring an oral treatment for hypoglycemia(midnight to 6 am)
  • Hypoglycemia with treatment(24 hours post-exercice)
  • Carbohydrate needed (g)(midnight to 6 am)

研究者

发起方
Institut de Recherches Cliniques de Montreal
申办方类型
Other
责任方
Principal Investigator
主要研究者

Rémi Rabasa-Lhoret

Professor of Medicine, Director, Research Platform on Obesity, Metabolism and Diabetes

Institut de Recherches Cliniques de Montreal

研究点 (1)

Loading locations...

相似试验